arBtrage CAPITALIZING MARKETS checking… Sign in

Alto Neuroscience, Inc.

ANRO Health Care Biotechnology: Pharmaceutical Preparations
$18.26
▼ -8.8% Today
as of Jun 7, 07:09 ET
Last 30 days -25.38% Apr 28 → Jun 05
$17.67 $19.81 $21.96 $24.11 $26.25 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$19.80
High
$20.21
Low
$17.95
Volume
$395,105
Avg Vol
$611,212
Mkt Cap
$710M
P/E (TTM)
Beta
52w High
$28.44
52w Low
$2.15
Div Yield
Shares Out
$35M

Overview

52-week range
$2.15
$28
61% of range
Avg surprise (last 2)
-16.3%
Avg reaction (last 2)
-7.2%
0% positive
Latest IV / EM
212%
EM ±29.3% · $18 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.44$-1.96$-1.48$-1.00$-0.52 Actual $-2.33Actual $-2.44Actual $-0.76Actual $-0.60Actual $-0.62Actual $-0.53Est $-0.59Actual $-0.65Actual $-0.52Actual $-0.80Est $-0.56 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-26M$-23M$-21M$-18M$-15M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.80 $-0.56 -42.9% -50.9% -7.2% earnings
Tue Sep 30, 2025Sep 2025 $-0.52 financials
Mon Jun 30, 2025Jun 2025 $-0.65 financials
Wed May 14, 2025Mar/2025 $-0.53 $-0.59 +10.2% -7.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.62 financials
Sun Jun 30, 2024Jun 2024 $-0.60 financials
Sun Mar 31, 2024Mar 2024 $-0.76 financials
Sat Sep 30, 2023Sep 2023 $-2.44 financials
Fri Jun 30, 2023Jun 2023 $-2.33 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-27M$-15M$-19M$-16M$-19M$-18M
Net income$-26M$-14M$-18M$-15M$-17M$-16M
EPS (diluted)$-0.80$-0.52$-0.65$-0.56$-0.62$-0.60

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$264M$176M$138M$148M$161M$168M$182M$193M
Inventory
Total current assets$269M$178M$139M$150M$164M$169M$184M$195M
Total assets$276M$185M$147M$158M$172M$178M$192M$197M
Long-term debt$14M$16M$20M$20M$20M$10M$7M$8M
Total liabilities$33M$34M$35M$34M$33M$26M$27M$18M
Total equity$243M$151M$112M$123M$139M$151M$165M$180M

Implied volatility — last 90 days

206%209%211%214%216% Jun 07 — IV 212% · EM ±29.3%

Sector peers